First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
Titel:
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients
Auteur:
Smith, I.E. Pierga, J.-Y. Biganzoli, L. Cortés-Funes, H. Thomssen, C. Pivot, X. Fabi, A. Xu, B. Stroyakovskiy, D. Franke, F.A. Kaufman, B. Mainwaring, P. Pienkowski, T. De Valk, B. Kwong, A. González-Trujillo, J.L. Koza, I. Petrakova, K. Pereira, D. Pritchard, K.I.